Profile
| Metric | Value |
|---|---|
| Full Name | Smith & Nephew plc |
| Ticker | NYSE: SNN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | smith-nephew.com |
| Employees | 17,349 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $32.88 | |
| Price, 1D Change | +0.21% | |
| Market Cap | $14B | |
| TTM Dividend Yield | 2.32% | |
| PE Ratio | - | |
| Beta | 0.49 | |
| Revenue | $6B | |
| Revenue, 1Y Change | +4.75% | |
| EPS | $0.94 | |
| EPS, 1Y Change | +56.18% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.30 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.94 | |
| EPS Estimate | $1.62 | |
| EPS Est. Change | +71.65% | |
| Revenue | $5.81B | |
| Revenue Estimate | $6.14B | |
| Revenue Est. Change | +5.60% | |
| Current Price | $32.88 | |
| Price Target | - | $37.50 |
| Price Tgt. Change | - | +14.05% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.39 | $0.94 | -32.45% | |
| $1.62 | N/A | +71.65% | |
| $1.80 | N/A | +91.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.77B | $5.81B | +0.66% | |
| $6.14B | N/A | +5.60% | |
| $6.46B | N/A | +11.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +34.75% | |
| Price, 3Y | +22.28% | |
| Market Cap, 1Y | +31.81% | |
| Market Cap, 3Y | +20.06% | |
| Revenue, 1Y | +4.75% | |
| Revenue, 3Y | +11.52% | |
| EPS, 1Y | +56.18% | |
| EPS, 3Y | -21.16% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $32.88 | |
| SMA 200 | $32.18 | |
| SMA 200 vs Price | -2.13% | |
| SMA 50 | $33.70 | |
| SMA 50 vs Price | +2.50% | |
| Beta | 0.49 | |
| ATR | $0.48 | |
| 14-Day RSI | 47.02 | |
| 10-Day Volatility | 9.66% | |
| 1-Year Volatility | 30.15% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.30 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.28% | |
| Total Dividend | $0.75 | |
| Dividends Paid | $327.14M | |
| Payout Ratio | 79.37% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $5.81B | |
| EPS | $0.94 | |
| Gross Profit | $3.86B | |
| Gross Margin | 66.35% | |
| Operating Profit | $974.41M | |
| Operating Margin | 16.76% | |
| Net Income | $412.17M | |
| Net Margin | 7.09% | |
| EBITDA | $1.53B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.63 | |
| Current Ratio | 2.89 | |
| Quick Ratio | 1.33 | |
| Interest Coverage | - | |
| F-Score | - | |
| Altman Z-Score | 3.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 9.60 | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $5.26B | |
| Cash & Equivalents | $619.00M | |
| Total Assets | $10.35B | |
| Current Assets | $4.42B | |
| Total Liabilities | $5.09B | |
| Current Liabilities | $1.53B | |
| Total Debt | $3.32B | |
| Short Term Debt | $63.00M | |
| Accounts Payable | $1.08B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $5.40B | |
| Operating Expenses | $2.88B | |
| Cost Of Goods Sold | $1.96B | |
| SG&A | $0.00 | |
| D&A | $555.23M | |
| Interest Expense | $0.00 | |
| Income Tax | $86.04M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $987.42M | |
| CFI | -$569.24M | |
| CFF | -$86.04M | |
| Capex | $381.16M | |
| Free Cash Flow | $606.26M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Bernstein | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| UBS | → | |
| Canaccord Genuity | → | |
| UBS | → | |
| Bernstein | → | |
| Redburn Partners | → |
Analyst sentiment
Institutional ownership
Screeners with SNN
Data Sources & References
- SNN Official Website www.smith-nephew.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/845982/000155837025010157/0001558370-25-010157-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/845982/000155837025002550/0001558370-25-002550-index.htm
- SNN Profile on Yahoo Finance finance.yahoo.com/quote/SNN
- SNN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/snn
FAQ
What is the ticker symbol for Smith & Nephew plc?
The ticker symbol for Smith & Nephew plc is NYSE:SNN
Does Smith & Nephew plc pay dividends?
Yes, Smith & Nephew plc pays dividends. The last payment was $0.30, with an ex-dividend date on October 3, 2025
What sector is Smith & Nephew plc in?
Smith & Nephew plc is in the Healthcare sector
What industry is Smith & Nephew plc in?
Smith & Nephew plc is in the Medical Devices industry
What country is Smith & Nephew plc based in?
Smith & Nephew plc is headquartered in United Kingdom
When did Smith & Nephew plc go public?
Smith & Nephew plc initial public offering (IPO) was on November 16, 1999
Is Smith & Nephew plc in the S&P 500?
No, Smith & Nephew plc is not included in the S&P 500 index
Is Smith & Nephew plc in the NASDAQ 100?
No, Smith & Nephew plc is not included in the NASDAQ 100 index
Is Smith & Nephew plc in the Dow Jones?
No, Smith & Nephew plc is not included in the Dow Jones index
When was Smith & Nephew plc last earnings report?
Smith & Nephew plc's most recent earnings report was on August 5, 2025
When does Smith & Nephew plc report earnings?
The next expected earnings date for Smith & Nephew plc is March 2, 2026
